TMS Therapy for Depression: Success Rates, What to Expect, and Who Responds Best
At a Glance
- TMS (Transcranial Magnetic Stimulation) is an FDA-cleared, non-invasive treatment for depression that uses magnetic pulses to stimulate underactive brain circuits.
- Success rates are impressive: 56-60% of treatment-resistant depression patients respond, and 30-35% achieve full remission.
- Best candidates: people who have failed 1-2 antidepressants but do not have psychotic features or active seizure disorders.
- Standard course: 36 sessions over 6 weeks, or as few as 5 days with the accelerated Stanford SAINT protocol.
- Insurance coverage is now widely available for major-depression diagnoses after medication failure.
If you have been living with depression that does not budge, no matter how many pills you try, how much therapy you attend, or how hard you work at the lifestyle basics, you are not “treatment-resistant” as a person. Your brain circuits are simply stuck in a pattern that medication alone cannot always break.
That is exactly the problem TMS therapy was designed to solve. And unlike many treatments that get hyped before the data catches up, TMS has decades of research, FDA clearance since 2008, and real-world outcomes that hold up outside of clinical trials.
In this guide, we will walk through how TMS works for depression at the brain level, what the success rates actually look like, who responds best (and who does not), what to expect during a treatment course, and how the newer accelerated protocols are changing the game.
How TMS Works for Depression: The Brain-Circuit Story
Depression is not simply a “chemical imbalance.” That outdated framing made antidepressants seem like the only logical fix. The more accurate picture: depression involves dysfunctional communication between specific brain networks, especially the left dorsolateral prefrontal cortex (DLPFC).
The DLPFC is part of the brain’s executive and emotional regulation system. In people with depression, activity in this region is often diminished, like a dimmer switch turned too low. Meanwhile, deeper limbic structures (the amygdala, the subgenual cingulate) may be overactive, driving rumination, negative bias, and emotional pain.
TMS sends focused magnetic pulses through the skull and into the DLPFC. Each pulse generates a small electrical current in the targeted neurons, gradually:
- Increasing excitability in the underactive prefrontal cortex
- Normalizing connectivity between the DLPFC and the limbic system
- Promoting neuroplasticity, the brain’s ability to rewire itself
- Shifting neurotransmitter activity (dopamine, serotonin, norepinephrine) downstream
Think of it less like flipping a switch and more like physical therapy for a brain circuit. Each session nudges the network a bit further toward healthy function. Over weeks, those nudges accumulate into lasting change.
Clinical Success Rates: What the Numbers Actually Show
Let’s talk data, because this is where TMS separates itself from a lot of wellness-world claims.
For treatment-resistant depression (TRD), defined as failure to respond adequately to at least one antidepressant trial, the large-scale outcomes look like this:
- Response rate (≥50% symptom reduction): 56-60%
- Remission rate (minimal or no symptoms): 30-35%
Those numbers come from major real-world registries and meta-analyses, not just cherry-picked trials. For context, the remission rate for a second antidepressant after the first fails is roughly 25% (STAR*D trial data). TMS outperforms that, and it does so without the systemic side effects of medication.
Durability of Results
One common question: “Does it last?” The data is encouraging. Studies show that 60-70% of TMS responders maintain their improvement at 12 months. Some patients need a brief “maintenance” course (a few sessions every few months) to sustain gains, similar to how some people stay on a low-dose antidepressant long-term.
Who Responds Best to TMS for Depression
TMS works well across a broad range of depressive presentations, but the research points to some clear patterns in who tends to get the best outcomes:
Strongest candidates:
- Moderate-to-severe major depressive disorder (MDD)
- Failed 1-2 adequate antidepressant trials (the “sweet spot” for TRD)
- No psychotic features (hallucinations, delusions)
- Motivated and able to attend the full treatment course
- Younger age may predict slightly better response (though older adults still benefit)
- Shorter duration of current depressive episode
May not be ideal for:
- Depression with psychotic features (may need ECT or antipsychotic augmentation first)
- Active seizure disorder or history of epilepsy (magnetic pulses carry a very small seizure risk)
- Metallic implants near the treatment site (e.g., cochlear implants, metal plates in the skull)
- Patients who have failed 5+ medication classes (response rates decline, though TMS can still be worth trying)
The Stanford SAINT Protocol: 5-Day Remission
In 2020, Stanford researchers published a study that turned heads across psychiatry. Their Stanford Accelerated Intelligent Neuromodulation Therapy (SAINT) protocol achieved a 79% remission rate in treatment-resistant depression, in just five days.
How is that possible? SAINT differs from standard TMS in several ways:
- Precision targeting: Uses functional MRI to identify each patient’s specific DLPFC-to-subgenual cingulate connection, rather than using a one-size-fits-all scalp measurement.
- Intermittent theta burst stimulation (iTBS): A more efficient pulse pattern that delivers therapeutic stimulation in 3 minutes instead of 19-37 minutes.
- High dose, compressed schedule: 10 sessions per day, 50-minute intervals between sessions, for 5 consecutive days (1,800 pulses per session, 90,000 total pulses).
What a TMS Treatment Course Looks Like
Knowing the science is one thing. Knowing what to actually expect in the chair is another. Here is a practical walkthrough:
Initial Consultation (Week 0)
You will meet with a psychiatrist or TMS-trained provider who will review your depression history, medication trials, and any contraindications. They will determine whether you are a good candidate and discuss protocol options.
Motor Threshold Mapping (Session 1)
Before treatment begins, the technician finds your “motor threshold”, the minimum magnetic pulse intensity needed to make your thumb twitch. This calibrates the machine to your individual brain. The treatment coil is then positioned over the left DLPFC using either anatomical landmarks or neuronavigation.
Treatment Sessions
| Parameter | Standard TMS | Theta Burst (iTBS) | Accelerated (SAINT-style) |
|---|---|---|---|
| Session duration | 19-37 minutes | 3-9 minutes | ~10 min per session |
| Sessions per day | 1 | 1 | 8-10 |
| Total treatment days | 30-36 (over 6-9 weeks) | 30-36 (over 6-9 weeks) | 5 consecutive days |
| Total pulses | ~108,000 | ~108,000 | ~90,000 |
| Response rate | 56-60% | Similar to standard | ~90% (open-label) |
| Remission rate | 30-35% | Similar to standard | ~79% (open-label) |
During each session, you sit in a reclined chair, fully awake. The coil is placed against your head and you feel a tapping or clicking sensation on your scalp. Most people describe it as mildly uncomfortable at first but easy to tolerate. You can read, listen to music, or simply sit. There is no anesthesia, no sedation, and no recovery time, you drive yourself home (or back to work) afterward.
Side Effects
TMS has one of the mildest side-effect profiles of any depression treatment:
- Common: Scalp discomfort at the stimulation site (usually fades after the first week), mild headache
- Uncommon: Lightheadedness, facial twitching during treatment
- Rare: Seizure (estimated <0.1% risk per treatment course)
- Not associated with: Weight gain, sexual dysfunction, GI problems, sedation, cognitive impairment, the side effects that make antidepressants so hard to tolerate
TMS vs Medication vs Ketamine for Treatment-Resistant Depression
If you are weighing your options, this comparison can help clarify the differences:
| Factor | TMS | Antidepressants (3rd+ trial) | Ketamine / Spravato |
|---|---|---|---|
| Response rate (TRD) | 56-60% | 15-25% | 60-70% |
| Remission rate (TRD) | 30-35% | 10-15% | 30-40% |
| Onset of effect | 2-4 weeks | 4-8 weeks | Hours to days |
| Side effects | Scalp discomfort, headache | Weight gain, sexual dysfunction, GI issues, sedation | Dissociation, nausea, blood pressure changes, bladder risk with chronic use |
| Durability | 12+ months (many patients) | Requires ongoing daily use | 2-4 weeks per infusion (requires boosters) |
| Time commitment | 36 sessions, 6 weeks (daily) | Daily pill, ongoing | 6 infusions over 2-3 weeks, then monthly boosters |
| Approximate cost | $6,000-$12,000 (often insured) | $10-$300/month | $2,400-$4,800 (IV course); Spravato may be insured |
| Insurance coverage | Widely covered after med failure | Generally covered | Spravato often covered; IV ketamine rarely |
Insurance Coverage for TMS Therapy
This used to be one of the biggest barriers to TMS. The good news: insurance coverage has expanded significantly over the past several years.
Most major insurers, including Medicare, Aetna, Blue Cross Blue Shield, Cigna, and UnitedHealthcare, now cover TMS for major depressive disorder when:
- You have a diagnosis of MDD (moderate to severe)
- You have failed at least one adequate antidepressant trial (some insurers require two)
- You have tried or considered psychotherapy
- You do not have contraindications (seizure disorder, metallic implants near the coil)
Out-of-pocket costs vary, but with insurance, many patients pay only their standard specialist copay per session. Without insurance, a full course of TMS typically runs $6,000-$12,000. Some clinics offer financing or payment plans.
If your insurer initially denies coverage, ask your provider to submit a peer-to-peer review, many denials are overturned on appeal, especially with documentation of failed medication trials.
Frequently Asked Questions
Is TMS therapy painful?
Most patients describe the sensation as a tapping or knocking on the scalp, uncomfortable at first, but something you quickly get used to. The discomfort typically fades after the first few sessions as your scalp habituates. It is not painful in the way a medical procedure might be, and no anesthesia is needed. If discomfort is an issue, your technician can adjust the coil position or ramp up intensity more gradually.
How long do TMS results last?
In clinical studies, 60-70% of responders maintain their improvement at 12 months. Some people sustain remission for years. Others may benefit from periodic maintenance sessions (a few sessions every few months) or a brief retreatment course if symptoms begin to return. Many patients also continue therapy and/or medication alongside TMS, which may improve long-term outcomes.
Can I take antidepressants while doing TMS?
Yes, and in fact most patients continue their current medications during TMS treatment. There is some evidence that combining TMS with antidepressants may produce better outcomes than either alone. Your psychiatrist will advise on any medication adjustments.
Does TMS work for anxiety too?
TMS is FDA-cleared for major depression, OCD, smoking cessation, and anxious depression (depression accompanied by anxiety symptoms). For generalized anxiety disorder on its own, the evidence is promising but TMS is not yet FDA-cleared specifically for that indication. Many patients with comorbid depression and anxiety see improvement in both.
Related Reading
This article is part of our detailed guide to TMS therapy. For more on how TMS works, other conditions it treats, and how to find a provider, see our complete resource:
